Dr. Michael Joseph Capozza, MD

Dr. Capozza practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Capozza's NPI, 1366829905, was assigned on May 4, 2015. Dr. Capozza graduated from USF Health Morsani College of Medicine in 2015. Dr. Capozza holds Florida license ME134691.

Dr. Capozza's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Capozza's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Capozza practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Capozza's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Capozza is board certified in internal medicine by the American Board of Internal Medicine. Dr. Capozza is licensed in Florida.

Dmand AI lists acute respiratory failure, cardiac arrhythmia, cellulitis, circulation problems, collapsed lung, congestive heart failure, electrolyte disorders and gastrointestinal bleeding among the conditions Dr. Capozza treats.

CMS data shows 630 Medicare services from Dr. Capozza across 4 procedure codes in 2024, for 236 Medicare patients. Medicare paid $52,166 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 236 Medicare patients who saw Dr. Capozza in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Capozza's median patient age at 74, with 50% women.

In 2024, Dr. Capozza wrote 319 Medicare Part D claims for 120 patients. 85% of them were for generic drugs. CMS names the drug for 69 of them, across 5 drugs with 11 or more claims each, at $3,724 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Capozza for performance year 2024, reported through an alternative payment model (APM). Dr. Capozza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Capozza graduated from USF Health Morsani College of Medicine in 2015.

Dr. Capozza is in network with 3 carriers, including Aetna, Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.